Libtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.

New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.

A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported

Composite lymphoma is an extremely rare clinical entity.

U. S. News & World Report When choosing a provider, it can be helpful to review other patients' experiences. U.S. News publishes patient...

Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer.

On April 3, 2020, the Food and Drug Administration approved new treatment for MDS related anemia.

We are making a few changes to our standard process. Here are the instructions for coming to the office during the COVID-19 pandemic.